Procter & Gamble Company (The) $PG Shares Sold by Truepoint Inc.

Truepoint Inc. decreased its position in Procter & Gamble Company (The) (NYSE:PG) by 0.3% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 114,901 shares of the company’s stock after selling 362 shares during the period. Procter & Gamble comprises 0.5% of Truepoint Inc.’s portfolio, making the stock its 26th largest holding. Truepoint Inc.’s holdings in Procter & Gamble were worth $18,306,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in PG. MOKAN Wealth Management Inc. boosted its stake in shares of Procter & Gamble by 13.7% in the second quarter. MOKAN Wealth Management Inc. now owns 15,319 shares of the company’s stock valued at $2,442,000 after purchasing an additional 1,846 shares during the period. Benjamin Edwards Inc. grew its stake in Procter & Gamble by 120.7% during the 1st quarter. Benjamin Edwards Inc. now owns 364,378 shares of the company’s stock valued at $62,098,000 after purchasing an additional 199,258 shares in the last quarter. Caliber Wealth Management LLC KS raised its position in shares of Procter & Gamble by 36.2% in the 2nd quarter. Caliber Wealth Management LLC KS now owns 17,798 shares of the company’s stock valued at $2,836,000 after purchasing an additional 4,730 shares in the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new position in shares of Procter & Gamble during the 2nd quarter valued at approximately $34,684,000. Finally, First Citizens Bank & Trust Co. grew its position in shares of Procter & Gamble by 12.8% during the second quarter. First Citizens Bank & Trust Co. now owns 156,874 shares of the company’s stock worth $24,993,000 after buying an additional 17,836 shares in the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other Procter & Gamble news, CEO Jon R. Moeller sold 11,684 shares of the business’s stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $1,778,655.32. Following the completion of the transaction, the chief executive officer owned 319,932 shares in the company, valued at approximately $48,703,248.36. The trade was a 3.52% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Balaji Purushothaman sold 490 shares of the stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $74,592.70. Following the completion of the transaction, the insider directly owned 12,616 shares of the company’s stock, valued at approximately $1,920,533.68. The trade was a 3.74% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 150,489 shares of company stock worth $23,529,864 over the last ninety days. 0.20% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the stock. Raymond James Financial reduced their price objective on shares of Procter & Gamble from $185.00 to $175.00 and set an “outperform” rating on the stock in a research note on Monday, October 20th. Weiss Ratings restated a “hold (c)” rating on shares of Procter & Gamble in a research note on Thursday. BNP Paribas reiterated an “outperform” rating and issued a $177.00 price target on shares of Procter & Gamble in a report on Friday, August 15th. Berenberg Bank boosted their target price on shares of Procter & Gamble from $152.00 to $154.00 and gave the company a “hold” rating in a research note on Wednesday, September 17th. Finally, BNP Paribas Exane reduced their price target on shares of Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating on the stock in a research report on Tuesday, September 23rd. Twelve investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $171.53.

Procter & Gamble Stock Down 0.2%

PG stock opened at $147.71 on Friday. The stock has a market cap of $345.16 billion, a PE ratio of 21.56, a price-to-earnings-growth ratio of 3.87 and a beta of 0.36. The firm’s 50-day simple moving average is $151.83 and its 200 day simple moving average is $156.61. Procter & Gamble Company has a fifty-two week low of $144.09 and a fifty-two week high of $180.43. The company has a quick ratio of 0.51, a current ratio of 0.71 and a debt-to-equity ratio of 0.46.

Procter & Gamble (NYSE:PG) last posted its earnings results on Friday, October 24th. The company reported $1.99 EPS for the quarter, topping the consensus estimate of $1.90 by $0.09. Procter & Gamble had a net margin of 19.74% and a return on equity of 32.63%. The firm had revenue of $22.39 billion during the quarter, compared to analysts’ expectations of $22.23 billion. During the same quarter in the prior year, the firm earned $1.93 EPS. Procter & Gamble’s quarterly revenue was up 3.0% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. As a group, sell-side analysts predict that Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, November 17th. Investors of record on Friday, October 24th will be given a $1.0568 dividend. This represents a $4.23 annualized dividend and a yield of 2.9%. The ex-dividend date is Friday, October 24th. Procter & Gamble’s dividend payout ratio (DPR) is currently 61.61%.

Procter & Gamble Company Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.